These changes compromise cellular homeostasis and drive inflammatory responses through pathways such as NF-κB signaling, which is known to enhance cytokine production (TNF-α (tumor necrosis factor-alpha) and IL-6 (interleukin-6)), and endothelial dysfunction [7,8]. The gene discussed is TNF; the disease is endothelial dysfunction.